![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Genotypic and phenotypic correlates of virologic response to the attachment inhibitor BMS-626529 in a short-term monotherapy study with its prodrug BMS-663068
|
|
|
Reported by Jules Levin
Glasgow Nov 11-15 2012
Nannan Zhou,1 Neelanjana Ray,2 Matthew Healy,1 David Langley,1 Carey Hwang,3 Max Lataillade,1 George J Hanna,2 Mark Krystal1
1Bristol-Myers Squibb, Research and Development, Wallingford, CT, USA; 2Bristol-Myers Squibb, Research and Development, Princeton, NJ, USA; 3Bristol-Myers Squibb, Research and Development, Hopewell, NJ, USA
![Glasgow1.gif](../images/112012/112012-5/Glasgow1.gif)
![Glasgow2.gif](../images/112012/112012-5/Glasgow2.gif)
![Glasgow3.gif](../images/112012/112012-5/Glasgow3.gif)
![Glasgow4.gif](../images/112012/112012-5/Glasgow4.gif)
![Glasgow5.gif](../images/112012/112012-5/Glasgow5.gif)
![Glasgow6.gif](../images/112012/112012-5/Glasgow6.gif)
![Glasgow7.gif](../images/112012/112012-5/Glasgow7.gif)
![Glasgow8.gif](../images/112012/112012-5/Glasgow8.gif)
![Glasgow9.gif](../images/112012/112012-5/Glasgow9.gif)
![Glasgow10.gif](../images/112012/112012-5/Glasgow10.gif)
![Glasgow11.gif](../images/112012/112012-5/Glasgow11.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|